The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Angiotensin Receptor Blockers (ARBs) Global Market Report 2023, the angiotensin receptor blockers (ARBs) market is expected to show promising growth in the forecast period.

The global angiotensin receptor blockers (ARBs) market is set to undergo a transformation, with expectations to grow from $8.02 billion in 2022 to $8.30 billion in 2023, reflecting a commendable compound annual growth rate (CAGR) of 3.5%. Looking ahead, the market is anticipated to further expand, reaching $9.40 billion in 2027, sustaining a consistent CAGR of 3.2%.

Cardiovascular Challenges: Propelling ARBs Market Growth
The increasing incidence of cardiovascular diseases stands as a significant catalyst in propelling the growth of the angiotensin receptor blockers market. Cardiovascular diseases, encompassing a spectrum of conditions impacting the heart or blood vessels, often correlate with atherosclerosis and an elevated risk of blood clots. Angiotensin receptor blockers play a pivotal role by aiding vein and artery relaxation, consequently lowering blood pressure and supporting the heart’s efficient blood-pumping function. In 2020, the Centers for Disease Control and Prevention reported that over 697,000 people in the United States succumbed to heart disease, representing one-fifth of all deaths. This alarming statistic underscores the crucial role ARBs play in mitigating cardiovascular diseases, steering the market toward growth.

Key Points:

• Cardiovascular Disease Impact: Associated with atherosclerosis and blood clot risks.
• ARBs Functionality: Facilitate vein and artery relaxation, reducing blood pressure.
• CDC Report (2020): Over 697,000 U.S. deaths attributed to heart disease.

Industry Titans: Major Players Shaping ARBs Market

The angiotensin receptor blockers market is shaped by influential industry players committed to advancing cardiovascular health. Key players such as Pfizer Inc., Novartis AG, and Merck & Co. Inc. play pivotal roles in steering the industry toward innovation and improved patient outcomes.

Key Players:

• Pfizer Inc.
• Novartis AG
• Merck & Co. Inc.
• AstraZeneca Plc.
• Bristol-Myers Squibb Company
• GSK Plc.
• Teva Pharmaceutical Industries Ltd.
• Daiichi Sankyo Company Limited
• Lupin Limited
• Reddy’s Laboratories Ltd.
• Takeda Pharmaceutical Company Limited
• Otsuka Pharmaceutical Co. Ltd.
• Lupin Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Boehringer Ingelheim Ltd.

Innovation Drive: The Rise of Product Innovation

Innovation emerges as a key trend, gaining prominence in the angiotensin receptor blockers market. Leading companies are channeling efforts into developing novel solutions that strengthen their market positions. A prime example is the 2021 launch of Novartis AG’s Entresto (sacubitril/valsartan). This innovative product received an expanded indication from the United States Food and Drug Administration to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. The clinical benefits are particularly pronounced in patients with a lower-than-normal left ventricular ejection fraction (LVEF). Notably, Entresto stands as the first and only therapy approved in the United States to treat patients with guideline-defined heart failure, encompassing both heart failure with reduced ejection fraction (HFrEF) and many with heart failure with preserved ejection fraction (HFpEF).

Innovation Highlights:

• Novartis’ Entresto: Expanded indication for heart failure patients.
• Clinical Benefits: Prominent in patients with lower-than-normal LVEF.
• Market Impact: First therapy approved for guideline-defined heart failure.

Comprehensive Market Segmentation: Products and Applications

The global angiotensin receptor blockers (ARBs) market exhibits a comprehensive segmentation, addressing diverse healthcare needs and applications.

1. By Product:
   • Valsartan
   • Telmisartan
   • Losartan
   • Irbesartan
   • Azilsartan
   • Olmesartan
2. By Application:
   • Hypertension
   • Cardiovascular Diseases
   • Kidney Diseases
   • Other Applications
3. By End User:
   • Hospitals
   • Specialty Clinics
   • Ambulatory Surgical Centers

Comprehensive Segmentation:

• Product Diversity: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan.
• Application Spectrum: Hypertension, cardiovascular diseases, kidney diseases, and more.
• End User Variability: Hospitals, specialty clinics, ambulatory surgical centers.

Global Dynamics: Regional Dominance and Growth Forecasts

In 2022, North America claimed the largest region in the angiotensin receptor blockers (ARBs) market share. Looking forward, Asia-Pacific is poised to emerge as the fastest-growing region in the forecast period. Regional healthcare dynamics, coupled with heightened awareness and ARB adoption, contribute to the regional growth disparities.

Regional Dynamics:

• North America Dominance: Largest region in 2022.
• Asia-Pacific Growth: Anticipated to be the fastest-growing region.

View More On The Angiotensin Receptor Blockers (ARBs) Market Report 2023 – https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report

Request A Sample Of The Global Angiotensin Receptor Blockers (ARBs) Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=8943&type=smp

The Angiotensin Receptor Blockers (ARBs) Global Market Report 2023  offers a comprehensive overview on the angiotensin receptor blockers (ARBs) market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the angiotensin receptor blockers (ARBs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Angiotensin Receptor Blockers (ARBs) Market Include:
1. Angiotensin Receptor Blockers (ARBs) Market Executive Summary
2. Angiotensin Receptor Blockers (ARBs) Market Segments
3. Angiotensin Receptor Blockers (ARBs) Market Size And Angiotensin Receptor Blockers (ARBs) Market Growth Rate
4. Key Angiotensin Receptor Blockers (ARBs) Market Trends
5. Major Angiotensin Receptor Blockers (ARBs) Market Drivers
……
25. Key Mergers And Acquisitions In The Angiotensin Receptor Blockers (ARBs) Market
26. Top Angiotensin Receptor Blockers (ARBs) Companies
27. Angiotensin Receptor Blockers (ARBs) Market Opportunities And Strategies
28. Angiotensin Receptor Blockers (ARBs) Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Mycoplasma Testing Global Market Report 2023
Porcine Plasma Feed Global Market Report 2023
Convalescent Plasma Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model